Literature DB >> 15272082

Herpes simplex virus type-1 induces IFN-alpha production via Toll-like receptor 9-dependent and -independent pathways.

Hubertus Hochrein1, Beatrix Schlatter, Meredith O'Keeffe, Cornelia Wagner, Frank Schmitz, Matthias Schiemann, Stefan Bauer, Mark Suter, Hermann Wagner.   

Abstract

Type I IFN production in response to the DNA virus herpes simplex virus type-1 (HSV-1) is essential in controlling viral replication. We investigated whether plasmacytoid dendritic cells (pDC) were the major tissue source of IFN-alpha, and whether the production of IFN-alpha in response to HSV-1 depended on Toll-like receptor 9 (TLR9). Total spleen cells or bone marrow (BM) cells, or fractions thereof, including highly purified pDC, from WT, TLR9, and MyD88 knockout mice were stimulated with known ligands for TLR9 or active HSV-1. pDC freshly isolated from both spleen and BM were the major source of IFN-alpha in response to oligodeoxynucleotides containing CpG motifs, but in response to HSV-1 the majority of IFN-alpha was produced by other cell types. Moreover, IFN-alpha production by non-pDC was independent of TLR9. The tissue source determined whether pDC responded to HSV-1 in a strictly TLR9-dependent fashion. Freshly isolated BM pDC or pDC derived from culture of BM precursors with FMS-like tyrosine kinase-3 ligand, produced IFN-alpha in the absence of functional TLR9, whereas spleen pDC did not. Heat treatment of HSV-1 abolished maturation and IFN-alpha production from all TLR9-deficient DC but not WT DC. Thus pDC and non-pDC produce IFN-alpha in response to HSV-1 via both TLR9-independent and -dependent pathways.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15272082      PMCID: PMC509215          DOI: 10.1073/pnas.0403555101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  BAC-VAC, a novel generation of (DNA) vaccines: A bacterial artificial chromosome (BAC) containing a replication-competent, packaging-defective virus genome induces protective immunity against herpes simplex virus 1.

Authors:  M Suter; A M Lew; P Grob; G J Adema; M Ackermann; K Shortman; C Fraefel
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

2.  Protective vaccination against primary and recurrent disease caused by herpes simplex virus (HSV) type 2 using a genetically disabled HSV-1.

Authors:  C S McLean; M Erturk; R Jennings; D N Challanain; A C Minson; I Duncan; M E Boursnell; S C Inglis
Journal:  J Infect Dis       Date:  1994-11       Impact factor: 5.226

3.  Interferons and the colony-stimulating factors IL-3 and GM-CSF enhance the IFN-alpha response in human blood leucocytes induced by herpes simplex virus.

Authors:  B Cederblad; G V Alm
Journal:  Scand J Immunol       Date:  1991-11       Impact factor: 3.487

4.  Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA.

Authors:  Sandra S Diebold; Tsuneyasu Kaisho; Hiroaki Hemmi; Shizuo Akira; Caetano Reis e Sousa
Journal:  Science       Date:  2004-02-19       Impact factor: 47.728

5.  Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8.

Authors:  Florian Heil; Hiroaki Hemmi; Hubertus Hochrein; Franziska Ampenberger; Carsten Kirschning; Shizuo Akira; Grayson Lipford; Hermann Wagner; Stefan Bauer
Journal:  Science       Date:  2004-02-19       Impact factor: 47.728

6.  Induction of interferon-alpha by glycoprotein D of herpes simplex virus: a possible role of chemokine receptors.

Authors:  H Ankel; D F Westra; S Welling-Wester; P Lebon
Journal:  Virology       Date:  1998-11-25       Impact factor: 3.616

7.  Vaccination with plasmid DNA activates dendritic cells via Toll-like receptor 9 (TLR9) but functions in TLR9-deficient mice.

Authors:  Barbara Spies; Hubertus Hochrein; Martin Vabulas; Katharina Huster; Dirk H Busch; Frank Schmitz; Antje Heit; Hermann Wagner
Journal:  J Immunol       Date:  2003-12-01       Impact factor: 5.422

8.  Helper virus-free transfer of herpes simplex virus type 1 plasmid vectors into neural cells.

Authors:  C Fraefel; S Song; F Lim; P Lang; L Yu; Y Wang; P Wild; A I Geller
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

9.  Herpes simplex virus type 1-induced interferon production and activation of natural killer cells in mice.

Authors:  H Kirchner; H Engler; C H Schröder; R Zawatzky; E Storch
Journal:  J Gen Virol       Date:  1983-02       Impact factor: 3.891

10.  Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells.

Authors:  Jennifer Lund; Ayuko Sato; Shizuo Akira; Ruslan Medzhitov; Akiko Iwasaki
Journal:  J Exp Med       Date:  2003-08-04       Impact factor: 14.307

View more
  154 in total

Review 1.  DNA-Based Biomaterials for Immunoengineering.

Authors:  Midori Maeda; Taisuke Kojima; Yang Song; Shuichi Takayama
Journal:  Adv Healthc Mater       Date:  2018-12-05       Impact factor: 9.933

2.  Activation of NF-κB in CD8+ dendritic cells Ex Vivo by the γ134.5 null mutant correlates with immunity against herpes simplex virus 1.

Authors:  Huali Jin; Yijie Ma; Zhipeng Yan; Bellur S Prabhakar; Bin He
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

3.  HSV Recombinant Vectors for Gene Therapy.

Authors:  Roberto Manservigi; Rafaela Argnani; Peggy Marconi
Journal:  Open Virol J       Date:  2010-06-18

Review 4.  Recent insights into the role of Toll-like receptors in viral infection.

Authors:  M Carty; A G Bowie
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330

5.  Interferon-α and interleukin-12 are induced, respectively, by double-stranded DNA and single-stranded RNA in human myeloid dendritic cells.

Authors:  Yuichi Katashiba; Rie Miyamoto; Akira Hyo; Keiko Shimamoto; Naoko Murakami; Makoto Ogata; Ryuichi Amakawa; Muneo Inaba; Shosaku Nomura; Shirou Fukuhara; Tomoki Ito
Journal:  Immunology       Date:  2010-09-28       Impact factor: 7.397

6.  Inhibition of a C-rich oligodeoxynucleotide on activation of immune cells in vitro and enhancement of antibody response in mice.

Authors:  Guang Yang; Min Wan; Yongsheng Zhang; Luguo Sun; Ran Sun; Dali Hu; Xiaojing Zhou; Li Wang; Xiuli Wu; Liying Wang; Yongli Yu
Journal:  Immunology       Date:  2010-12       Impact factor: 7.397

7.  Myxoma virus induces type I interferon production in murine plasmacytoid dendritic cells via a TLR9/MyD88-, IRF5/IRF7-, and IFNAR-dependent pathway.

Authors:  Peihong Dai; Hua Cao; Taha Merghoub; Francesca Avogadri; Weiyi Wang; Tanvi Parikh; Chee-Mun Fang; Paula M Pitha; Katherine A Fitzgerald; Masmudur M Rahman; Grant McFadden; Xiaoyu Hu; Alan N Houghton; Stewart Shuman; Liang Deng
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

Review 8.  A proteomics perspective on viral DNA sensors in host defense and viral immune evasion mechanisms.

Authors:  Marni S Crow; Aaron Javitt; Ileana M Cristea
Journal:  J Mol Biol       Date:  2015-02-26       Impact factor: 5.469

9.  Role for plasmacytoid dendritic cells in the immune control of recurrent human herpes simplex virus infection.

Authors:  Heather Donaghy; Lidija Bosnjak; Andrew N Harman; Valerie Marsden; Stephen K Tyring; Tze-Chiang Meng; Anthony L Cunningham
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

10.  HSV ICP0 recruits USP7 to modulate TLR-mediated innate response.

Authors:  Sandrine Daubeuf; Divyendu Singh; Yaohong Tan; Hongiu Liu; Howard J Federoff; William J Bowers; Khaled Tolba
Journal:  Blood       Date:  2008-10-24       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.